Visiting Professorship in Head & Neck Surgery

Published On 01/06/2014

In this quarterly series, visiting professors from around the world share expertise in the latest treatments and advancements in head and neck surgery.

University of Tennessee Health Science CenterThis series is sponsored by Methodist University Hospital and University of Tennessee Health Science Center. This no-charge CME activity is offered to all ENT’s, medical oncologists and radiation oncologists. 


January 9: Bruce Haughey, MD, presents "Transoral Approaches in the Era of HPV Related Oropharynx Cancer"

Department of Otolaryngology, Washington University School of Medicine
View flyer for details (JPG)

April 10: Gregory T. Wolf, MD, presents "Organ Preservation Treatment Approaches for Laryngeal and Oropharyngeal Cancer: Changing the Paradigm"

View flyer (JPG)

Join webcast for this event

Dr. Wolf is Professor and Chair Emeritus of the Department of Otolaryngology - Head and Neck Surgery and Director of the Head and Neck SPORE Program at the University of Michigan in Ann Arbor.

Following this activity, learners will be able to:

  1. Identify the basis of using tumor biology to select patients for organ conserving treatment approaches.
  2. Understand the role of surgery in organ preservation approaches.
  3. Incorporate tumor biology into personalized treatment selection.

August 21: Brian B. Burkey, MD, MEd, presents "Oral Cavity Cancer: Searching to Find the Optimal Management" 

View flyer (JPG)

6:00 p.m. Presentation begins
7:00 p.m. Dinner begins

Hamilton Eye Institute Auditorium 
910 Madison Avenue, 3rd Floor

Register for this event

Dr. Burkey is Section Head of the Head and Neck Surgery and Oncology, Vice-chairman of the Head and Neck Institute, and Medical Director for the Center for Consumer Health Information at Cleveland Clinic Foundation.

Following this activity, learners will be able to:

1. Describe the pathology and natural history of oral cavity cancers
2. Describe the appropriate management plan of early oral cavity cancers
3. Identify two factors that may alter current management schemas

October 9: TBD

Registration & More Information